Journal article icon

Journal article

Antidepressant effects of intermittent theta-burst stimulation are associated with lower baseline regional gray matter volumes and surface areas in prefrontal cortex

Abstract:
Introduction: Major depressive disorder (MDD) is a leading cause of disability worldwide. Intermittent theta-burst stimulation (iTBS) is an effective neuromodulation treatment for MDD, yet treatment response varies and its mechanisms remain unclear. Individual differences in cortical morphology in regions linked to depression may influence treatment outcomes.

Objective: To investigate whether baseline cortical morphology, specifically gray matter volumes (GMV), surface area (SA) and cortical thickness (CT) of the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC), are predictive to clinical response to a validated iTBS treatment for MDD.

Methods: As part of the BRAEN-MAP trial, fifty-nine patients with MDD underwent daily iTBS sessions targeting the left DLPFC. Depressive symptoms were assessed weekly using the 17-item Hamilton Depression Rating Scale (HDRS-17). Pretreatment structural MRI data were processed with FreeSurfer to extract GMV, SA, and CT from bilateral DLPFC and ACC. Associations with symptom improvement were tested using mixed linear models.

Results: Fifty patients (mean age = 39.98 years, SD=10.79; 84.6% female) were included in the analysis. HDRS-17 scores decreased from 18.23 (SD=2.67) to 8.0 (SD=5.1) after six weeks. Smaller baseline GMV in the left DLPFC (area p9-46v) and right pregenual ACC (area s32), as well as reduced SA in bilateral DLPFC (p9-46v, 8C, a9-46v, 46, 8Av, i6.8) and ACC subregions (s32, d32, 25, a32pr), were significantly associated with greater symptom improvement. No associations were found for CT.

Conclusion: A significant association between individual cortical morphology and depression improvement after iTBS was seen, showing that variations in pretreatment cortical structure may influence neuromodulation treatment efficacy.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.jpsychires.2025.11.006

Authors

More by this author
Role:
Author
ORCID:
0000-0002-7627-4425
More by this author
Role:
Author
ORCID:
0000-0002-7806-6603
More by this author
Role:
Author
ORCID:
0000-0002-0230-7474
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author
ORCID:
0000-0002-5796-5378
More by this author
Role:
Author
ORCID:
0000-0002-5667-4552


Publisher:
Elsevier
Journal:
Journal of Psychiatric Research More from this journal
Volume:
193
Pages:
179-187
Publication date:
2025-11-07
Acceptance date:
2025-11-07
DOI:
EISSN:
1879-1379
ISSN:
0022-3956


Language:
English
Keywords:
Pubs id:
2328157
UUID:
uuid_5afc5d38-9d30-4936-bcc2-d06541715c57
Local pid:
pubs:2328157
Deposit date:
2025-11-24
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP